These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2644585)

  • 21. A multicenter clinical study of cefoperazone.
    Alix M; Arreza V; Brillantes S; Estrellado R; Gempesaw C; Monteron R; Pascasio F; Pena A; Claudio-Saniel M
    Clin Ther; 1984; 6(3):344-53. PubMed ID: 6722861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multicenter study of the clinical efficacy and tolerance of roxithromicin compared to doxycycline in lower respiratory infections].
    Charpin J; Freour P; Marsac J
    Pathol Biol (Paris); 1988 May; 36(5):548-51. PubMed ID: 3043355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
    J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections].
    Płusa T; Nawacka D
    Pol Merkur Lekarski; 1998 Dec; 5(30):368-71. PubMed ID: 10101527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
    Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
    Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of a new semisynthetic penicillin derivative: piperacillin. Clinical and experimental research].
    Romeo R; Sorace R; Libertini C; Santangelo C; Patanè S; Di Stefano F; Gatto A
    G Ital Chemioter; 1981; 28(1-2):61-4. PubMed ID: 6751918
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of cefoperazone in the treatment of bacterial infections in patients with hematological diseases.
    Ichimaru M; Takatsuki K; Niho Y; Sawae Y
    Clin Ther; 1984; 7(1):60-8. PubMed ID: 6518464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
    Oyabu Y
    Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of lower respiratory tract infections with cefoperazone.
    Kaplowitz LG; Sarubbi FA
    Clin Ther; 1983; 5(3):243-50. PubMed ID: 6221798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of cephalexin in common infections in general practice.
    Practitioner; 1970 Dec; 205(230):815-8. PubMed ID: 4924137
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.
    Nishiura T
    Clin Ther; 1980; 3(Spec Issue):190-205. PubMed ID: 6446394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of netilmicin with cefoperazone for the treatment of severe or complicated urinary tract infections.
    Bailey RR; Peddie BA; Lynn KL; Swainson CP
    Aust N Z J Med; 1985 Feb; 15(1):22-6. PubMed ID: 3890818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cefoperazone--Possibility of safer treatment for infections in patients with chronic renal failure].
    Klinger M; Szewczyk Z; Kazimierczak K; Kramarz S
    Wiad Lek; 1990 Aug 1-15; 43(15-16):773-6. PubMed ID: 2275197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vibramycin treatment of respiratory and urinary tract diseases].
    Bojanowicz K; Pieter R; Kapczynska K; Mroszczyk M; Szymański R
    Wiad Lek; 1970 Jul; 23(14):1223-8. PubMed ID: 5455915
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CEFOBID in the treatment of respiratory tract infection (preliminary report)].
    Filipecki S; Hajduk B; Tomkowski W; Lipowski D; Janowiec M; Styszewska H; Pawlicka L
    Pneumonol Pol; 1989; 57(7-9):403-8. PubMed ID: 2699921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Controlled trial of Cymbi on efficacy and tolerance (author's transl)].
    Bräuer H; Villanyi P; Votin J
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):353-6. PubMed ID: 804644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.